Challenges and Solutions for Future Pharmacy Practice in the Era of Precision Medicine
Olivia M Dong(University of North Carolina at Chapel Hill), Tim Wiltshire(University of North Carolina at Chapel Hill), Angela D. M. Kashuba(University of North Carolina at Chapel Hill), Federico Innocenti(AbbVie (United States)), Daniel González(University of North Carolina at Chapel Hill), Merrie Mosedale(University of North Carolina at Chapel Hill), Mackenzie L. Cottrell(University of North Carolina at Chapel Hill), Rachel J. Church(University of North Carolina at Chapel Hill), Rachel Howard(University of North Carolina at Chapel Hill), Alan Forrest(University of North Carolina at Chapel Hill)
Cited by 6
Related Papers
Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy
|Nature|2012|1.2k
Gemcitabine Plus Bevacizumab Compared With Gemcitabine Plus Placebo in Patients With Advanced Pancreatic Cancer: Phase III Trial of the Cancer and Leukemia Group B (CALGB 80303)
|Journal of Clinical Oncology|2010|840
ctDNA applications and integration in colorectal cancer: an NCI Colon and Rectal–Anal Task Forces whitepaper
|Nature Reviews Clinical Oncology|2020|365
Penetration of Tenofovir and Emtricitabine in Mucosal Tissues: Implications for Prevention of HIV-1 Transmission
|Science Translational Medicine|2011|352